AAAAAA
Results:
1-12
|
Results: 12
Authors:
Lepercq, J
Conard, J
Borel-Derlon, A
Darmon, JY
Boudignat, O
Francoual, C
Priollet, P
Cohen, C
Yvelin, N
Schved, JF
Tournaire, M
Borg, JY
Citation: J. Lepercq et al., Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies, BR J OBST G, 108(11), 2001, pp. 1134-1140
Authors:
Neerman-Arbez, M
de Moerloose, P
Honsberger, A
Parlier, G
Arnuti, B
Biron, C
Borg, JY
Eber, S
Meili, E
Peter-Salonen, K
Ripoll, L
Vervel, C
d'Oiron, R
Staeger, P
Antonarakis, SE
Morris, MA
Citation: M. Neerman-arbez et al., Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes, HUM GENET, 108(3), 2001, pp. 237-240
Authors:
Le Querrec, A
Arnout, J
Arnoux, D
Borg, JY
Caron, C
Darnige, L
Delahousse, B
Reber, G
Sie, P
Citation: A. Le Querrec et al., Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies, THROMB HAEM, 86(2), 2001, pp. 584-589
Authors:
Levesque, H
Borg, JY
Bossi, P
Goudemand, J
Guillet, B
Cabane, J
Citation: H. Levesque et al., Acquired haemophilia: diagnosis and therapeutic management., REV MED IN, 22(9), 2001, pp. 854-866
Authors:
Vasse, M
Massardier, EG
Borg, JY
Woimont, F
Soria, C
Citation: M. Vasse et al., Frequency of protein Z deficiency in patients with ischaemic stroke - Reply, LANCET, 358(9284), 2001, pp. 840-841
Authors:
Vasse, M
Guegan-Massardier, E
Borg, JY
Woimant, F
Soria, C
Citation: M. Vasse et al., Frequency of protein Z deficiency in patients with ischaemic stroke, LANCET, 357(9260), 2001, pp. 933-934
Authors:
Guedon, C
Le Cam-Duchez, V
Lalaude, O
Menard, JF
Lerebours, E
Borg, JY
Citation: C. Guedon et al., Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play a role in venous thrombosis in inflammatory bowel disease, AM J GASTRO, 96(5), 2001, pp. 1448-1454
Authors:
Aillaud, MF
Morange, P
Juhan, I
Bauters, A
Jude, B
Biron-Andreani, C
Daures, JP
Schved, JF
Pernod, G
Polac, B
Bridey, F
De Prost, D
Borg, JY
Saladin-Theron, C
Le Cam, V
Denninger, MH
Truchaud, F
Trossaert, M
Boinot, C
Sultan, Y
Delahousse, B
Fimbel, B
Gruel, Y
Houbouyan, L
Bihour, C
Vergnes, C
Dutrillaux, F
Lorenzini, JL
Julia, A
Deschamps, A
Favier, R
Freyburger, G
Trzeciak, MC
Berruyer, M
Doumergue, G
Gris, JC
Toulon, P
Montpied, G
Marques-Verdier, A
Lequerrec, A
Guerin, V
Massignon, D
Citation: Mf. Aillaud et al., Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotescarriers of the factor V Leiden mutation: retrospective analysis from the Procare Study, BL COAG FIB, 11(6), 2000, pp. 511-518
Authors:
Marie, I
Levesque, H
Lecam-Duchez, V
Borg, JY
Ducrotte, P
Philippe, C
Citation: I. Marie et al., Mesenteric venous thrombosis revealing both factor II G20210A mutation andhyperhomocysteinemia related to pernicious anemia, GASTROENTY, 118(1), 2000, pp. 237-238
Authors:
Pouplard, C
Amiral, J
Borg, JY
Laporte-Simitsidis, S
Delahousse, B
Gruel, Y
Citation: C. Pouplard et al., Decision analysis for use of platelet aggregation test, carbon 14 serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia, AM J CLIN P, 111(5), 1999, pp. 700-706
Authors:
Verspyck, E
Le Cam-Duchez, V
Gravier, A
Descargues, G
Marpeau, L
Borg, JY
Citation: E. Verspyck et al., Small for gestational age infant in association with maternal prothrombin gene variant (nt 20210A), EUR J OB GY, 83(2), 1999, pp. 143-144
Authors:
Le Cam-Duchez, V
Gandrille, S
Tregouet, D
Alhenc-Gelas, M
Emmerich, J
Fiessinger, JN
Borg, JY
Aiach, M
Citation: V. Le Cam-duchez et al., Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor VArg 506 to Gln mutation, BR J HAEM, 106(4), 1999, pp. 889-897
Risultati:
1-12
|